FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088291245> ?p ?o ?g. }

• W3088291245 endingPage "6641" @default.
• W3088291245 startingPage "6633" @default.
• W3088291245 abstract "Nitroxoline is considered to be an effective treatment for the urinary tract infections. Recently, it has been found to be effective against several cancers. However, few studies have examined the anti-tumor activity of nitroxoline in bladder cancer. The purpose of the study was to reveal the possible mechanisms how nitroxoline inhibited bladder cancer progression. In vitro assay, we demonstrated that nitroxoline inhibited bladder cancer cell growth and migration in a concentration-related manner. Western blot analysis demonstrated that nitroxoline downregulated the expressions of epithelial mesenchymal transition (EMT)-related proteins. Furthermore, treatment with nitroxoline in the C3H/He mice bladder cancer subcutaneous model resulted in significant inhibition of tumor growth. Moreover, the percentage of myeloid-derived suppressor cells (MDSC) in peripheral blood cells significantly decreased after treatment of nitroxoline. Taken together, our results suggested that nitroxoline may be used as a potential drug for bladder cancer." @default.
• W3088291245 created "2020-10-01" @default.
• W3088291245 creator A5002406824 @default.
• W3088291245 creator A5010415397 @default.
• W3088291245 creator A5015347913 @default.
• W3088291245 creator A5022666245 @default.
• W3088291245 creator A5033441324 @default.
• W3088291245 creator A5043031303 @default.
• W3088291245 creator A5055828343 @default.
• W3088291245 creator A5066671671 @default.
• W3088291245 creator A5073501872 @default.
• W3088291245 creator A5075234540 @default.
• W3088291245 creator A5084874214 @default.
• W3088291245 creator A5089279867 @default.
• W3088291245 date "2020-01-01" @default.
• W3088291245 modified "2023-10-03" @default.
• W3088291245 title "Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity" @default.
• W3088291245 cites W1826848231 @default.
• W3088291245 cites W1986785675 @default.
• W3088291245 cites W2002906868 @default.
• W3088291245 cites W2003835776 @default.
• W3088291245 cites W2058160302 @default.
• W3088291245 cites W2064890942 @default.
• W3088291245 cites W2074166462 @default.
• W3088291245 cites W2076583198 @default.
• W3088291245 cites W2084413504 @default.
• W3088291245 cites W2143598351 @default.
• W3088291245 cites W2167872699 @default.
• W3088291245 cites W2173889361 @default.
• W3088291245 cites W2473162054 @default.
• W3088291245 cites W2595920893 @default.
• W3088291245 cites W2771183993 @default.
• W3088291245 cites W2891478207 @default.
• W3088291245 cites W2901968479 @default.
• W3088291245 cites W2924146440 @default.
• W3088291245 cites W2971302725 @default.
• W3088291245 cites W2978344608 @default.
• W3088291245 cites W3005627675 @default.
• W3088291245 cites W4232492554 @default.
• W3088291245 cites W4250649173 @default.
• W3088291245 doi "https://doi.org/10.7150/jca.47025" @default.
• W3088291245 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7545671" @default.
• W3088291245 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33046984" @default.
• W3088291245 hasPublicationYear "2020" @default.
• W3088291245 type Work @default.
• W3088291245 sameAs 3088291245 @default.
• W3088291245 citedByCount "6" @default.
• W3088291245 countsByYear W30882912452021 @default.
• W3088291245 countsByYear W30882912452022 @default.
• W3088291245 crossrefType "journal-article" @default.
• W3088291245 hasAuthorship W3088291245A5002406824 @default.
• W3088291245 hasAuthorship W3088291245A5010415397 @default.
• W3088291245 hasAuthorship W3088291245A5015347913 @default.
• W3088291245 hasAuthorship W3088291245A5022666245 @default.
• W3088291245 hasAuthorship W3088291245A5033441324 @default.
• W3088291245 hasAuthorship W3088291245A5043031303 @default.
• W3088291245 hasAuthorship W3088291245A5055828343 @default.
• W3088291245 hasAuthorship W3088291245A5066671671 @default.
• W3088291245 hasAuthorship W3088291245A5073501872 @default.
• W3088291245 hasAuthorship W3088291245A5075234540 @default.
• W3088291245 hasAuthorship W3088291245A5084874214 @default.
• W3088291245 hasAuthorship W3088291245A5089279867 @default.
• W3088291245 hasBestOaLocation W30882912451 @default.
• W3088291245 hasConcept C104317684 @default.
• W3088291245 hasConcept C121608353 @default.
• W3088291245 hasConcept C126322002 @default.
• W3088291245 hasConcept C127716648 @default.
• W3088291245 hasConcept C185592680 @default.
• W3088291245 hasConcept C203014093 @default.
• W3088291245 hasConcept C2776415932 @default.
• W3088291245 hasConcept C2779013556 @default.
• W3088291245 hasConcept C2780352672 @default.
• W3088291245 hasConcept C502942594 @default.
• W3088291245 hasConcept C55493867 @default.
• W3088291245 hasConcept C70883133 @default.
• W3088291245 hasConcept C71924100 @default.
• W3088291245 hasConcept C76419328 @default.
• W3088291245 hasConceptScore W3088291245C104317684 @default.
• W3088291245 hasConceptScore W3088291245C121608353 @default.
• W3088291245 hasConceptScore W3088291245C126322002 @default.
• W3088291245 hasConceptScore W3088291245C127716648 @default.
• W3088291245 hasConceptScore W3088291245C185592680 @default.
• W3088291245 hasConceptScore W3088291245C203014093 @default.
• W3088291245 hasConceptScore W3088291245C2776415932 @default.
• W3088291245 hasConceptScore W3088291245C2779013556 @default.
• W3088291245 hasConceptScore W3088291245C2780352672 @default.
• W3088291245 hasConceptScore W3088291245C502942594 @default.
• W3088291245 hasConceptScore W3088291245C55493867 @default.
• W3088291245 hasConceptScore W3088291245C70883133 @default.
• W3088291245 hasConceptScore W3088291245C71924100 @default.
• W3088291245 hasConceptScore W3088291245C76419328 @default.
• W3088291245 hasIssue "22" @default.
• W3088291245 hasLocation W30882912451 @default.
• W3088291245 hasLocation W30882912452 @default.
• W3088291245 hasLocation W30882912453 @default.
• W3088291245 hasLocation W30882912454 @default.
• W3088291245 hasLocation W30882912455 @default.
• W3088291245 hasOpenAccess W3088291245 @default.

• next